Clinical trial
A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine
NCT00109330 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00109330 |
|---|---|
| Title | A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine |
| Official title | A Phase III, Observer-blinded Randomised, Multi-centre Clinical Study of the Safety, Immunogenicity and Consistency of Three Manufacturing Lots of GSK Biologicals' Candidate Tdap Vaccine as Compared to a US-licensed Td Vaccine When Given as a Booster Dose to Healthy Adolescents (10-18 Years of Age) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diphtheria, Tetanus, Acellular Pertussis |
| Intervention type | Biological |
| Interventions | Combined diphtheria, tetanus, acellular pertussis vaccine |
| Enrollment | 4,116 |
| Start date | Nov 1, 2002 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Apr 27, 2005 |
| Last update posted | Sep 9, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: